• Latest Posts

An EU Project will tackle Multiple Sclerosis using Personalized Multi Omics

Here comes the First-ever Combination Therapy for Multiple Sclerosis

Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment

UPDATE: Novartis is Favoured to Win the Race for a New MS Drug

Roche’s New Antibody is besting the best MS Drug

First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!


French Biotech gets €34M to bring Multiple Sclerosis Drug to the US

Sanofi-Genzyme: Still successful 5 years after the acquisition?

Apitope relocates to Wales after €12M series B financing round

Novartis signs $1Bn deal for GSK’s Multiple Sclerosis Antibody

After two failed IPOs, Mapi Pharma raised €9 Million from private investors

Genzyme joins the never-ending list of Ablynx’ partners